Pimivalimab
Based on 1 Customer Validation
Pimivalimab (JTX-4014) is an anti-PD-1 IgG4 monoclonal antibody. Pimivalimab binds to PD-1, blocking its interaction with PD-L1 and PD-L2, and enhances antitumor immune activity. Pimivalimab can be used for research on advanced or metastatic renal cell carcinoma and metastatic non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 2293951-22-9
- Molecular Weight:144.9 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
PDCD1/PD-1/CD279
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized PD-1 Protein, Human (143a.a, HEK293, His, HY-P7396) can bind Pimivalimab. The EC50 for this effect is 4.21 ng/mL.
Product Details
-
CAS No. 2293951-22-9
-
Accession Q15116
-
Synonyms JTX-4014
-
Molecular Weight 144.9 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG4 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG4 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
-
Data Sheet (267 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)